Diagnostic Assay Development

About arcoris bio

Arcoris Bio is an early-stage biotech company commercializing a novel, enzyme-free DNA nanotechnology platform called MUSE® for multiplex biomarker detection. The platform addresses key limitations in sensitivity, specificity, and multiplexing capability for imaging techniques used in research and diagnostics, offering a simple, same-day workflow without specialized equipment. Founded by Simon Restrepo, Kaspar Binz, and Scott Fraser, the company targets the growing market for spatial biology and multiplexed assays in translational research, with a vision to eventually impact clinical diagnostics and personalized medicine.

Therapeutic Areas

Other Oncology & Other Diseases Drugs